EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Disulfidptosis-related long non-coding RNA signature predicts the prognosis, tumor microenvironment, immunotherapy, and antitumor drug options in colon adenocarcinoma

Kang Wang, Jing Yu, Qihuan Xu, Yuanhong Peng, Haibin Li, Yan Lu, Manzhao Ouyang

Apoptosis · 2024

DOI: 10.1007/s10495-024-02011-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Apoptosis, 2024. Verfasst von Kang Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde Foshan), Shunde, Foshan, …. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Colonic Neoplasms, Tumor Microenvironment, Adenocarcinoma. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Natural Science Foundation of Guangdong Province, China, the 2021 Special Innovation Project of Department of Education of Guangdong Province, Foshan City's 13th Five-Year Key Specialty Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to investigate the role and prognostic significance of long non-coding RNAs (lncRNAs) associated with disulfidptosis in colon adenocarcinoma (COAD). The TCGA database’s clinical data and transcriptome profiles were employed. Analysis of previous studies identified 10 disulfidptosis-related genes (DRGs). We used these genes to construct a signature that could independently and accurately predict the prognosis of patients with COAD. The Kaplan-Meier (K-M) curve analysis showed that the lower-risk group had a better prognosis. With the help of multivariate Cox regression analysis, the risk score produced from the patient’s signature might independently predict the outcomes. Utilizing a nomogram, the receiver operating characteristic (ROC) curve, and principal component analysis (PCA), the signature’s predictive ability was also confirmed. It’s interesting to note that immunotherapy, especially PD-1 immune checkpoint suppression, was more likely to benefit low-risk patients. The IC50 levels for certain anticancer agents were lower in the high-risk group. Finally, qRT-PCR analyses in colon cancer cell lines revealed elevated levels of lncRNAs CASC9, ZEB1-AS1, ATP2A1-AS1, SNHG7, AL683813.1, and AP003555.1, and reduced levels of FAM160A1-DT and AC112220.2, compared to normal cell lines. This signature offers insights into prognosis, tumor microenvironment, and options for immunotherapy and antitumor drugs in patients with COAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingColonic NeoplasmsTumor MicroenvironmentAdenocarcinomaImmunotherapyAntineoplastic AgentsGene Expression Regulation, NeoplasticHumansPrognosisBiomarkers, TumorMaleApoptosisCell Line, TumorFemaleTranscriptome

Stichwörter der Autor:innen

Colon adenocarcinomaDisulfidptosisImmune microenvironmentImmunotherapyLncRNAPrognosis

Substanzen

RNA, Long NoncodingAntineoplastic AgentsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde Foshan), Shunde, Foshan, Guangdong Province, 528300, China.
  • The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510080, China.
  • Guangdong Medical University, Zhanjiang, Dongguan, 523808, China. veryan0532@163.com.
  • GCP Center, Shunde Hospital, Southern Medical University, The First People's Hospital of Shunde Foshan), Foshan, Guangdong, 528300, China. veryan0532@163.com.
  • Department of Gastrointestinal Surgery, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde Foshan), Shunde, Foshan, Guangdong Province, 528300, China. doctorken@smu.edu.cn.
  • The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510080, China. doctorken@smu.edu.cn.

Förderung

  • the Natural Science Foundation of Guangdong Province, China
  • the 2021 Special Innovation Project of Department of Education of Guangdong Province
  • Foshan City's 13th Five-Year Key Specialty Project
  • Scientific Research Start Plan of Shunde Hospital, Southern Medical University
  • Foshan City’s 13th Five-Year Key Specialty Project

Zitieren

APA

Wang, K., Yu, J., Xu, Q., Peng, Y., Li, H., Lu, Y., & Ouyang, M. (2024). Disulfidptosis-related long non-coding RNA signature predicts the prognosis, tumor microenvironment, immunotherapy, and antitumor drug options in colon adenocarcinoma. Apoptosis. https://doi.org/10.1007/s10495-024-02011-x

Vancouver

Wang K, Yu J, Xu Q, Peng Y, Li H, Lu Y, et al. Disulfidptosis-related long non-coding RNA signature predicts the prognosis, tumor microenvironment, immunotherapy, and antitumor drug options in colon adenocarcinoma. Apoptosis. 2024. doi:10.1007/s10495-024-02011-x

BibTeX
@article{Wang2024,
  author = {Wang, Kang and Yu, Jing and Xu, Qihuan and Peng, Yuanhong and Li, Haibin and Lu, Yan and Ouyang, Manzhao},
  title = {Disulfidptosis-related long non-coding RNA signature predicts the prognosis, tumor microenvironment, immunotherapy, and antitumor drug options in colon adenocarcinoma},
  journal = {Apoptosis},
  year = {2024},
  doi = {10.1007/s10495-024-02011-x}
}
Kostenlos starten →